Track Your Weight Loss Progress with ShapeScale As your body reshapes with GLP-1s, it can be hard to see subtle changes with the scale alone
Summary: Retatrutide and tesamorelin are both peptide-based compounds used in metabolic medicine, but retatrutide is an unapproved triple incretin receptor agonist in clinical trials, while tesamorelin is a GHRH analogue licensed in the US for HIV-associated lipodystrophy but unlicensed in the UK
Lets start with the basics
-20 C for extended hold Packaging Crimp-sealed, tamper-evident research vial Supplier Retatrutide Peptide (Australia) WHY CHOOSE RETATRUTIDE PEPTIDE Retatrutide Peptide is the Australian research-peptide supplier built around retatrutide and its supporting bench compounds
Patients who have experienced allergic reactions to other GLP-1 receptor agonists should be evaluated carefully before initiating treatment with this formulation, as cross-reactivity between different GLP-1 receptor agonists may occur in some individuals
The drug has been associated with benefits like improved glycemic control, enhanced insulin sensitivity, and better metabolic support